Author

V. Kotapalli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Assay:proteomics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

M. D. Bashyam· 3 shared P. Kavadipula· 2 shared S. Gowrishankar· 2 shared A. K. Singh· 1 shared P. Bala· 1 shared P. Ramaswamy· 1 shared R. Kumar· 1 shared R. Sabarinathan· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

M. D. Bashyam

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Identification of novel oncogenic transcriptional targets of mutant p53 in Esophageal Squamous Cell Carcinoma

S. A. George, V. Kotapalli, P. Ramaswamy, R. Kumar, S. Gowrishankar, S. G. Uppin, M. D. Bashyam

This study identifies novel oncogenic targets of rare non-hotspot p53 mutations in ESCC and validates their functional roles in tumorigenesis.

bioRxiv · Mar 12, 2023 · PreprintCancer Biology

Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer

P. Bala, A. K. Singh, P. Kavadipula, V. Kotapalli, R. Sabarinathan, M. D. Bashyam

Oncogene · Dec 1, 2020Peer-reviewedCancer Biology

Cytoplasm localized ARID1B promotes oncogenesis in pancreatic cancer by activating RAF-ERK signaling

S. Animireddy, P. Kavadipula, V. Kotapalli, S. Gowrishankar, S. Rao, M. D. Bashyam

This study shows that cytoplasmic ARID1B promotes pancreatic cancer by activating RAF-ERK signaling and β-catenin transcription.

bioRxiv · Nov 7, 2019 · PreprintCell Biology